Skip to content

Lipid Screening & Cardiovascular Risk

Learning Objectives

Core Knowledge & Clinical Reasoning

  • [ ] Apply universal lipid screening protocol (ages 9-11 and 17-21)
  • [ ] Identify indications for targeted screening in younger children (family history, obesity, high-risk conditions)
  • [ ] Interpret pediatric-specific lipid cut points (LDL ≥130 high, ≥160 suspect FH)
  • [ ] Recognize familial hypercholesterolemia and indications for genetic testing

Management Decisions

  • [ ] Prescribe lifestyle modifications using CHILD-1/CHILD-2 diets
  • [ ] Determine pharmacotherapy indications (age ≥10, LDL thresholds by risk factors)
  • [ ] Select appropriate statin therapy for pediatric patients

Communication & Counseling

  • [ ] Counsel families on cardiovascular risk reduction and atherosclerosis prevention
  • [ ] Explain rationale for screening even without family history (unreliability of family history)
  • [ ] Address concerns about statin use in children when indicated

Systems-Based Practice

  • [ ] Implement universal screening into well-child care protocols
  • [ ] Coordinate cascade testing for families with identified FH

Key Guidelines

2011 NHLBI Expert Panel: Integrated Guidelines for CV Health and Risk Reduction in Children Pediatrics. 2011;128(Suppl):S213-256 AAP Endorsed; Remains Current

Universal Screening

Age Recommendation
9-11 years Universal non-fasting lipid screen
17-21 years Second universal screen

Rationale

  • Family history unreliable for identifying dyslipidemia
  • Early atherosclerosis is present and preventable
  • FH prevalence ~1:250 (underdiagnosed)

Targeted Screening (Ages 2-8 Years)

Screen if ANY of the following: - Family history of early CVD (<55 years male, <65 years female) - Family history of dyslipidemia - Parent with TC ≥240 mg/dL - BMI ≥95th percentile - Diabetes, hypertension, or tobacco use - High-risk conditions: - Chronic kidney disease - Kawasaki disease with coronary aneurysms - Solid organ transplant - Childhood cancer survivor

Lipid Cut Points for Children

Lipid Acceptable Borderline High
Total Cholesterol <170 170-199 ≥200
LDL-C <110 110-129 ≥130
Non-HDL-C <120 120-144 ≥145
TG (0-9 years) <75 75-99 ≥100
TG (10-19 years) <90 90-129 ≥130
HDL-C >45 40-45 <40 (low)

All values in mg/dL

Screening Method

Non-Fasting Lipid Panel

  • Preferred for screening
  • TC, HDL-C, Non-HDL-C valid non-fasting
  • If Non-HDL-C ≥145 or HDL <40 → repeat fasting

Fasting Lipid Panel

  • Confirm abnormal screening
  • Required for accurate TG and LDL-C calculation

Familial Hypercholesterolemia (FH)

Suspect FH if:

  • LDL-C ≥160 mg/dL (pediatric threshold)
  • Family history of early CVD or high cholesterol
  • Tendon xanthomas (rare in children)

Genetic Testing

  • Consider if LDL-C ≥190 mg/dL
  • Cascade testing if proband positive

Management

Lifestyle Modifications (All Patients)

  • CHILD-1 diet (low saturated fat, no trans fat)
  • Regular physical activity
  • Weight management if overweight/obese
  • Avoid tobacco exposure

Pharmacotherapy Indications

Age ≥10 years with: - LDL-C ≥190 mg/dL despite diet, OR - LDL-C ≥160 mg/dL + family history or other risk factors, OR - LDL-C ≥130 mg/dL + diabetes

Statins are first-line (multiple are FDA-approved for pediatric use)

2023 USPSTF Statement

  • "Insufficient evidence" to assess benefits/harms of universal screening
  • Does NOT recommend against screening
  • Acknowledges NHLBI/AAP guidance
  • Continues to generate controversy

Board Pearls

Pearl: Universal screening at 9-11 years and 17-21 years

Non-fasting lipid panel; family history is unreliable

Pearl: Pediatric LDL-C ≥160 = suspect FH

Lower threshold than adults; early detection critical

Pearl: Non-HDL-C: Most useful non-fasting marker

Calculate as: TC - HDL-C

Self-Assessment

Q1: A healthy 10-year-old presents for a well-child check. Mother's cholesterol is unknown. What lipid screening is indicated?

Answer **Answer**: Universal non-fasting lipid screening **Rationale**: Per NHLBI/AAP guidelines, all children should have universal lipid screening at ages 9-11 years. This does not depend on family history, which is unreliable for identifying dyslipidemia.

Q2: A 7-year-old with BMI at 97th percentile has fasting lipids: TC 210, LDL 145, HDL 38, TG 135. What is the interpretation and management?

Answer **Answer**: High LDL-C, low HDL-C, borderline TG; lifestyle modification first **Rationale**: LDL 145 is high (≥130), HDL 38 is low (<40), TG is borderline-high for age. In a 7-year-old, lifestyle modifications (CHILD-1/CHILD-2 diet, exercise, weight management) are first-line. Pharmacotherapy is generally reserved for age ≥10 with more severe elevations or FH.

References

  • NHLBI Expert Panel. Pediatrics. 2011;128(Suppl):S213-256
  • USPSTF Statement 2023